GLENMARK — Glenmark Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Glenmark Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	C2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	Interim Report
Standards:	—	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	9,378	11,112	11,381	14,105	12,892
Net Total Accounts Receivable
Net Total Receivables	28,279	28,666	34,152	39,359	36,652
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	66,968	68,036	73,596	82,823	84,236
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	33,322	40,683	41,756	46,117	41,951
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	132,956	146,848	156,036	170,833	193,717
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	40,211	41,260	42,010	46,894	45,462
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	76,905	86,143	85,390	79,966	98,978
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	56,052	60,705	70,646	90,866	94,739
Total Liabilities & Shareholders' Equity	132,956	146,848	156,036	170,833	193,717
Total Common Shares Outstanding